DOCSLIB.ORG

Identifying New Healthcare Technologies

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Identifying New Healthcare Technologies Health Technology Assessment 1999; Vol. 3: No. 13 ‘Early warning systems’ for identifying new healthcare technologies G Robert A Stevens J Gabbay Health Technology Assessment NHS R&D HTA Programme HTA Standing Group on Health Technology Current members Chair: Professor John Gabbay, Professor Maggie Pearson, Professor Tom Walley, Professor Sir Miles Irving, Director, Wessex Institute for Regional Director of R&D, Department of Professor of Surgery, University Health Research & Development NHS Executive North West Pharmacological Therapeutics, of Manchester, Hope Hospital, Mr Hugh Ross, University of Liverpool Salford Professor Sir John Grimley Evans, Chief Executive, The United Dr Julie Woodin, Department of Bristol Healthcare NHS Trust Chief Executive, Professor Martin Buxton, Geriatric Medicine, Professor Trevor Sheldon, Nottingham Health Authority Professor of Economics, Radcliffe Infirmary, Oxford Director, NHS Centre for Brunel University Professor Kent Woods Dr Tony Hope, Reviews & Dissemination, University of York (Chair Designate), Professor Francis Creed, The Medical School, School of Psychiatry Professor Mike Smith, Regional Director of R&D, University of Oxford NHS Executive, Trent & Behavioural Sciences, Director, The Research University of Manchester Professor Richard Lilford, School of Medicine, Regional Director, R&D, University of Leeds Professor Charles Florey, West Midlands Department of Epidemiology Dr John Tripp, & Public Health, Ninewells Dr Jeremy Metters, Department of Child Health, Hospital & Medical School, Deputy Chief Medical Officer, Royal Devon & Exeter University of Dundee Department of Health Healthcare NHS Trust Past members Dr Sheila Adam, Professor Howard Mrs Gloria Oates, Professor Ian Russell, Department of Health Glennester, Chief Executive, Department of Health Sciences Professor Angela Coulter, Professor of Social Science Oldham NHS Trust & Clinical Evaluation, & Administration, London University of York Director, King’s Fund, London School of Economics & Dr George Poste, Professor Anthony Culyer, Political Science Chief Science & Technology Dr Charles Swan, Officer, SmithKline Beecham Consultant Gastroenterologist, Deputy Vice-Chancellor, Mr John H James, University of York North Staffordshire Chief Executive, Professor Michael Rawlins, Royal Infirmary Dr Peter Doyle, Kensington, Chelsea & Wolfson Unit of Executive Director, Zeneca Ltd, Westminster Health Authority Clinical Pharmacology, University of Newcastle- ACOST Committee on Medical Professor Michael Maisey, Research & Health upon-Tyne Professor of Radiological Professor John Farndon, Sciences, Guy’s, King’s & St Professor Martin Roland, Professor of Surgery, Thomas’s School of Medicine Professor of General Practice, University of Bristol & Dentistry, London University of Manchester Details of the membership of the HTA panels, the NCCHTA Advisory Group and the HTA Commissioning Board are given at the end of this report. HTA How to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (http://www.hta.ac.uk). A fully searchable CD-ROM is also available (see below). Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents. Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph. You can order HTA monographs from our Despatch Agents: – fax (with credit card or official purchase order) – post (with credit card or official purchase order or cheque) – phone during office hours (credit card only). Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact details are as follows: HTA Despatch Email: [email protected] c/o Direct Mail Works Ltd Tel: 02392 492 000 4 Oakwood Business Centre Fax: 02392 478 555 Downley, HAVANT PO9 2NP, UK Fax from outside the UK: +44 2392 478 555 NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30–40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Payment methods Paying by cheque If you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit card The following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase order You can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD? Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide. The website also provides information about the HTA Programme and lists the membership of the various committees. ‘Early warning systems’ for identifying new healthcare technologies G Robert1 A Stevens2 J Gabbay3 1 Health Economics Research Group, Brunel University, Uxbridge, UK 2 Department of Public Health and Epidemiology, University of Birmingham, UK 3 Wessex Institute for Health Research and Development, University of Southampton, UK Competing interests None declared Published July 1999 This report should be referenced as follows: Robert G, Stevens A, Gabbay J.‘Early warning systems’ for identifying new healthcare technologies. Health Technol Assess 1999;3(13). Health Technology Assessment is indexed in Index Medicus/MEDLINE and Excerpta Medica/ EMBASE. Copies of the Executive Summaries are available from the NCCHTA web site (see overleaf). NHS R&D HTA Programme he overall aim of the NHS R&D Health Technology Assessment (HTA) programme is to T ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and work in the NHS. Research is undertaken in those areas where the evidence will lead to the greatest benefits to patients, either through improved patient outcomes or the most efficient use of NHS resources. The Standing Group on Health Technology advises on national priorities for health technology assessment. Six advisory panels assist the Standing Group in identifying and prioritising projects. These priorities are then considered by the HTA Commissioning Board supported by the National Coordinating Centre for HTA (NCCHTA). This report is one of a series covering acute care, diagnostics and imaging, methodology, pharmaceuticals, population screening, and primary and community care. It was identified as a priority by the Methodology Panel and funded as project number 94/10/02. The views expressed in this publication are those of the authors and not necessarily those of the Standing Group, the Commissioning Board, the Panel members or the Department of Health. The editors wish to emphasise that funding and publication of this research by the NHS should not be taken as implicit support for the recommendations for policy contained herein. In particular, policy options in the area of screening will be considered by the National Screening Committee. This Committee, chaired by the Chief Medical Officer, will take into account the views expressed here, further available evidence and other relevant considerations. Reviews in Health Technology Assessment are termed ‘systematic’ when the account of the search, appraisal and synthesis methods (to minimise biases and random errors) would, in theory, permit the replication of the review by others. Series Editors: Andrew Stevens, Ruairidh Milne and Ken Stein Editorial Assistant: Melanie Corris The editors have tried to ensure the accuracy of this report but cannot accept responsibility for any errors or omissions. They would like to thank the referees for their constructive comments on the draft document. ISSN 1366-5278 © Crown copyright 1999 Enquiries relating to copyright should be addressed to the NCCHTA (see address given below). Published by Core Research, Alton, on behalf of the NCCHTA. Printed on acid-free paper in the UK by The Basingstoke Press, Basingstoke. Copies of this report can be obtained from: The National Coordinating Centre for Health Technology Assessment, Mailpoint 728, Boldrewood, University of Southampton, Southampton, SO16 7PX, UK. Fax: +44 (0) 1703 595 639 Email: [email protected] http://www.hta.nhsweb.nhs.uk Health Technology Assessment 1999; Vol. 3: No. 13 Contents List of abbreviations .................................... i 7 Synthesis of results ....................................... 57 Information sources ....................................... 57 Executive summary .................................... iii Establishment and operation of an EWS ...... 62 1 Aims ............................................................... 1 8 Conclusions and research 2 Background and rationale for the study ... 3 recommendations ........................................ 67 The need for an early warning
Load more

Recommended publications
  • Economic Evaluation of a Primary Care-Based Education Programme for Patients with Osteoarthritis of the Knee
    Health Technology Assessment 1999; Vol. 3: No. 23 Economic evaluation of a primary care-based education programme for patients with osteoarthritis of the knee J Lord C Victor P Littlejohns FM Ross JS Axford Health Technology Assessment NHS R&D HTA Programme HTA Standing Group on Health Technology Current members Chair: Professor John Gabbay Dr Jeremy Metters Dr John Tripp Professor Kent Woods Director, Wessex Institute Deputy Chief Medical Officer, Senior Lecturer in Child Health, Professor of Therapeutics, for Health Research Department of Health Royal Devon and Exeter University of Leicester & Development Professor Maggie Pearson Healthcare NHS Trust Regional Director of R&D, Professor Sir John Professor Tom Walley Professor Martin Buxton NHS Executive North West Grimley Evans Director, Director & Professor of Professor of Clinical Geratology, Mr Hugh Ross Prescribing Research Group, Health Economics, Radcliffe Infirmary, Chief Executive, University of Liverpool Health Economics Oxford The United Bristol Research Group, Healthcare NHS Trust Dr Julie Woodin Brunel University Dr Tony Hope Professor Trevor Sheldon Clinical Reader in Medicine, Chief Executive, Professor Shah Ebrahim Joint Director, York Health Nuffield Department of Nottingham Health Authority Professor of Epidemiology Policy Group, University of York Clinical Medicine, of Ageing, University of Bristol University of Oxford Professor Mike Smith Professor Francis H Creed Faculty Dean of Research Professor of Professor Richard Lilford for Medicine, Dentistry, Psychological
    [Show full text]
  • Autologous Chondrocyte Implantation for Cartilage Defects in Knee Joints ISSN 1366-5278 Feedback Your Views About This Report
    Health Technology Assessment Health Technology Health Technology Assessment 2005; Vol. 9: No. 47 2005; 9: No. 47 Vol. Autologous chondrocyte implantation for cartilage defects in knee joints Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation C Clar, E Cummins, L McIntyre, S Thomas, Feedback J Lamb, L Bain, P Jobanputra and N Waugh The HTA Programme and the authors would like to know your views about this report. The Correspondence Page on the HTA website (http://www.ncchta.org) is a convenient way to publish your comments. If you prefer, you can send your comments to the address below, telling us whether you would like us to transfer them to the website. We look forward to hearing from you. December 2005 The National Coordinating Centre for Health Technology Assessment, Mailpoint 728, Boldrewood, Health Technology Assessment University of Southampton, NHS R&D HTA Programme Southampton, SO16 7PX, UK. HTA Fax: +44 (0) 23 8059 5639 Email: [email protected] http://www.ncchta.org ISSN 1366-5278 HTA How to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (http://www.ncchta.org). A fully searchable CD-ROM is also available (see below). Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents, York Publishing Services. Non-UK purchasers will have to pay a small fee for post and packing.
    [Show full text]
  • In the Spotlight: Community Nursing  ODUJHWUXVWRIWKH\HDU Contents
    the February 2010 issue 16 In the spotlight: community nursing ODUJHWUXVWRIWKH\HDU contents 2 Dialysis unit brings care closer to home 3 A word from David 3 South London HIEC bid successful 4 Hole-hearted 4 Welcome Sanjay Sharma 4 Joined-up thinking will benefit Wandsworth patients 5 New clinical director for A&E 5 New technology delivers clearer scans in seconds 6 New Trust website 6 March deployment date for iCLIP 7 Vaccination heroes 8 In the spotlight Amor Marasigan (left), Clinical Manager for the north Wandsworth satellite dialysis unit, with Karen Jones, dialysis nurse 9 View from the top 10 Foundation Trust: Q&A 11 10:10 Dialysis treatment is 12 PM visits St George’s 12 A&E nurse visits No 10 moved closer to home 12 Stop smoking drop-in clinics A new satellite dialysis unit has opened in Battersea for St George’s renal 13 Clean sweep (kidney) patients so they can get treatment closer to home. 13 Welcome news The centre, run by Fresenius Medical Care Renal Services, operates in addition to the 13 V&A delivers new collection renal department at St George’s and serves patients from north Wandsworth and surrounding areas. St George’s renal consultants, specialist nurses and dieticians visit 14 Appraisal: Have you had yours? their patients at the unit on a regular basis. 14 Training leaders The unit has 18 individual dialysis stations which come with adjustable electronic 14 Chief Executive congratulates chairs and their own flat screen TV. A wireless network is also available which One Team Service Partners patients can access for their own computers.
    [Show full text]
  • A Randomised Controlled Trial of Larval Therapy in the Management of Leg Ulcers
    This is a repository copy of VenUS II : a randomised controlled trial of larval therapy in the management of leg ulcers. White Rose Research Online URL for this paper: https://eprints.whiterose.ac.uk/75220/ Version: Published Version Article: Dumville, J. C., Worthy, G., Soares, M. O. orcid.org/0000-0003-1579-8513 et al. (8 more authors) (2009) VenUS II : a randomised controlled trial of larval therapy in the management of leg ulcers. Health technology assessment. pp. 1-220. ISSN 2046-4924 https://doi.org/10.3310/hta13550 Reuse Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version. This is indicated by the licence information on the White Rose Research Online record for the item. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ Health Technology Assessment 2009; Vol. 13: No. 55 VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers JC Dumville, G Worthy, MO Soares, JM Bland, N Cullum, C Dowson, C Iglesias, D McCaughan, JL Mitchell, EA Nelson and DJ Torgerson on behalf of the VenUS II team November 2009 DOI: 10.3310/hta13550 Health Technology Assessment NIHR HTA programme www.hta.ac.uk HTA How to obtain copies of this and other HTA programme reports An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk).
    [Show full text]
  • Curriculum Vitae
    1 January 1, 2016 CURRICULUM VITAE Name: Michael M. Haglund, M.D., Ph.D., FAANS, FCS (ECSA) Address: Distinguished Professor of Neurosurgery, Neurobiology, and Global Health with Tenure, Vice Chair Education, Department of Neurosurgery, Program and Training Director, Duke Neurosurgery, Co-Director, Ugandan Neurosurgery Training Program Surgical Director, Duke Epilepsy Center Department of Neurosurgery, Box 3807 Duke University Medical Center Durham, NC 27710 (919)-684-6936, office (919)-684-4902, lab (919)-681-6566, fax [email protected], email Education: 1980 B.S. Pacific Lutheran University (magna cum laude) Tacoma, Washington (Chemistry) 1987 M.D. University of Washington School of Medicine (with Honors), Seattle, Washington. 1988 Ph.D. Physiology and Biophysics, University of Washington, Seattle, Washington. 2016 MACM University of Southern California, Masters in Academic Medicine (Education), in progress, graduation on track for Summer 2016. Academic Training: 1981-83 Medical Student Research Trainee, Neurological Surgery, University of Washington 1983-88 Medical Scientist, Predoctoral Trainee, Department of Physiology and Biophysics, University of Washington, (Philip A. Schwartzkroin, PhD) 2 1987, June Visiting Scientist, Department of Physiology, University of Calgary, Alberta, Canada 1987-88 General Surgery Internship, University of Washington Affiliated Hospitals, Seattle, Washington 1988-92 Resident Physician, Department of Neurological Surgery, University of Washington Hospitals, Seattle, Washington 1988, 1990 Research Fellow in Neurobiology, Harvard Medical School, Boston, Massachusetts (Gary G. Blasdel, PhD, Visual Neuroscience Group led by David Hubel, MD) 1989-90 American Epilepsy Society, William Lennox Fellow 1989-90 Grass Foundation, Robert S. Morison Fellow 1990-92 American Association of Neurological Surgeons Research Foundation Fellow 1992-94 Klingenstein Fellow in the Neurosciences, Department of Neurobiology, Harvard Medical School, Boston, MA 1992-93 Senior Registrar, Atkinson Morley’s Hospital, St.
    [Show full text]
  • No Need for Metadata Here
    Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys AJ Avery,1* C Anderson,1 CM Bond,2 H Fortnum,1 A Gifford,3 PC Hannaford,2 L Hazell,4 J Krska,5 AJ Lee,2 DJ McLernon,2 E Murphy,6 S Shakir4 and MC Watson2 1University of Nottingham, Nottingham, UK 2University of Aberdeen, Aberdeen, UK 3Keele University, Keele, Newcastle-under-Lyme, UK 4Drug Safety Research Unit, Southampton, Southampton, UK 5Liverpool John Moores University, Liverpool, UK 6University of Leicester, Leicester, UK *Corresponding author Declared competing interests of authors: none Published April 2011 DOI: 10.3310/hta15200 This report should be referenced as follows: Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, et al. Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess 2011;15(20). Health Technology Assessment is indexed and abstracted in Index Medicus/MEDLINE, Excerpta Medica/EMBASE, Science Citation Index Expanded (SciSearch) and Current Contents/ Clinical Medicine. ii NIHR Health Technology Assessment programme The Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. ‘Health technologies’ are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care.
    [Show full text]
  • Aggressive Versus Symptomatic Therapy in Established Rheumatoid Arthritis ISSN 1366-5278 Feedback Your Views About This Report
    Health Technology Assessment Health Technology Health Technology Assessment 2005; Vol. 9: No. 34 2005; 9: No. 34 Vol. Aggressive versus symptomatic therapy in established rheumatoid arthritis The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis Feedback D Symmons, K Tricker, C Roberts, L Davies, The HTA Programme and the authors would like to know P Dawes and DL Scott your views about this report. The Correspondence Page on the HTA website (http://www.ncchta.org) is a convenient way to publish your comments. If you prefer, you can send your comments to the address below, telling us whether you would like us to transfer them to the website. We look forward to hearing from you. September 2005 The National Coordinating Centre for Health Technology Assessment, Mailpoint 728, Boldrewood, Health Technology Assessment University of Southampton, NHS R&D HTA Programme Southampton, SO16 7PX, UK. HTA Fax: +44 (0) 23 8059 5639 Email: [email protected] http://www.ncchta.org ISSN 1366-5278 HTA How to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (http://www.hta.ac.uk). A fully searchable CD-ROM is also available (see below). Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents. Non-UK purchasers will have to pay a small fee for post and packing.
    [Show full text]
  • A Randomised Controlled Trial of Post-Operative Radiotherapy Following Breast-Conserving Surgery in a Minimum-Risk Population
    Health Technology Assessment 2011; Vol. 15: No. 12 ISSN 1366-5278 A randomised controlled trial of post-operative radiotherapy following breast-conserving surgery in a minimum-risk population. Quality of life at 5 years in the PRIME trial LJ Williams, IH Kunkler, CC King, W Jack and M van der Pol March 2011 10.3310/hta15120 Health Technology Assessment NIHR HTA programme www.hta.ac.uk HTA How to obtain copies of this and other HTA programme reports An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below). Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents. Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order: – fax (with credit card details) – post (with credit card details or cheque) – phone during office hours (credit card only). Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows: Synergie UK (HTA Department) Email: [email protected] Digital House, The Loddon Centre Tel: 0845 812 4000 – ask for ‘HTA Payment Services’ Wade Road (out-of-hours answer-phone service) Basingstoke Hants RG24 8QW Fax: 0845 812 4001 – put ‘HTA Order’ on the fax header Payment methods Paying by cheque If you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address.
    [Show full text]
  • Accuracy of Bacterial DNA Testing for Central Venous Catheter-Associated Bloodstream Infection in Children with Cancer
    Health Technology Assessment 2011; Vol. 15: No.71 Rationale Health Technology Assessment 2011; Vol. 15: No. 7 AbstractMethods Results GlossaryConclusions ChapterList of abbreviations 6 Discussion ExecutiveMain findings summary StudyBackground limitations ImplicationsObjectives for practice RecommendationsMethods for research Results AcknowledgementsConclusions Accuracy of bacterial DNA testing for ContributionRecommendations of authors for research Trial registration central venous catheter-associated ReferencesFunding bloodstream infection in children with ChapterAppendix 1 1 ProtocolBackground for the and accuracy rationale study (Chapter 2) cancer SynopsisChildren with cancer Diagnosis of central venous catheter-associated infection AppendixRationale 2 for the study DataOverview collection of the sheets study (accuracy study, Chapter 2) M Millar, W Zhou, R Skinner, B Pizer, ChapterAppendix 2 3 E Hennessy, M Wilks and RE Gilbert PrognosticAccuracy markers of DNA for testing sequelae for centralof central venous venous catheter-associated catheter-associated bloodstream infection in infection:children 6-month with cancer follow-up period (Chapter 3) Introduction Appendix 4 Methods Slow infusion versus bolus infection for treating suspected central venous catheter- Results associated infection (Chapter 4) Discussion Appendix 5 ChapterSearch 3 terms for the systematic review (Chapter 4) Prognostic markers for sequelae of central venous catheter-associated Search for papers on prognosis bloodstream infection Cochrane Central Register of
    [Show full text]
  • Godfrey Hounsfield
    Outstanding Contributions Over the Last 50 Years 50 Years of IOMP 1963-2013 Godfrey Hounsfield Sir Godfrey Newbold Hounsfield CBE, FRS was an electrical engineer, who was awarded the Nobel Prize for Physiology or Medicine for developing X-ray computed tomography (CT). Its introduction was a fundamental advance of the greatest importance to diagnostic medicine. His name is immortalised in the Hounsfield scale, a measure of electron density which is used in evaluating CT scans. In September 1939, Hounsfield joined the RAF as a volunteer reservist and worked as a radar mechanic instructor during the war. After the war he obtained a grant to study electrical and mechanical engineering at Faraday House in London and then joined the research staff of Electric and Musical Instruments (EMI) at their Central Research Laboratories to work on radar and guided weapons. He became interested in computers and led the team that built the UK’s first all-transistor computer: the EMIDEC 1100. In those days, transistors were much slower than valves. Hounsfield overcame this problem by using a magnetic core to drive the transistor. This led to transistors being used in computing earlier than would otherwise have been possible. Shortly after this, he began working on pattern recognition and became interested in developing a computer that could take Figure1. Hounsfield’s sketch for a CT scanner. measurements from X-rays at various angles to build up a three-dimensional picture of an object. Hounsfield’s first experimental system successfully scanned a pig’s brain in 1968. The scanning process took nine days and required two and a half hours to process the resulting 28,000 measurements on a high-speed computer.
    [Show full text]
  • MRIS History UK
    MRIS History UK THE DEVELOPMENT OF M AGNETIC RESONANCE IM AGING AND SPECTROSCO PY MRIS History UK © MRIS History UK Authors [email protected] Graeme Bydder Table of Contents Biography 1. Computed Tomography (CT) at the Medical Research Council (MRC) Clinical Research Centre (CRC), Northwick Park Hospital (NPH), London 2. The Hammersmith Nuclear Magnetic Resonance Unit 3. Multiple Sclerosis 4. The Winston-Salem NMR Meeting Oct 1-3, 1981: Changing of the Guard 5. Clinico-Industrial Groups: Clinical and Commercial Realities 6. The Long Echo Time (TE) Heavily T2 Weighted Spin Echo (SE) Pulse Sequence 7. Spin-warp and K-space 8. The Multi Sequence Approach (MSA) 9. The Brain 10. High Field versus Low Field 11. Paediatric Brain 12. Contrast Agents 13. Blood Flow and Cardiac Imaging 14. The Short inversion Time Inversion Recovery (STIR) Pulse Sequence and Respiratory Ordered Phase Encoding (ROPE) 15. The Fourth SMRM Meeting at the Barbican London, August 19-23, 1985 16. Magnetic Resonance Spectroscopy (MRS) 17. Further Low Field Development 18. Susceptibility 19. Diffusion Weighted Imaging 20. The Fluid Attenuated Inversion Recovery (FLAIR) Pulse Sequence 21. The Interventional System and Internal Coils 22. Registration of Images 23. The Neonatal System 24. Ultrashort Echo Time (UTE) Pulse Sequences 25. University of California, San Diego (UCSD) 26. Epilogue 27. References 28. Acknowledgements 29. Chronology 30. Gallery MRIS HISTORY UK Biography BYDDER, Graeme Mervyn b Motueka, New Zealand (NZ) 1.5.1944, m 19.12.70 Patricia Anne Hamilton b 14.8.47 (artist, writer, secretary). 2d Megan b ’72 (radiologist, Manchester UK; Merrin Hamilton b ’76 (music teacher, Luxembourg), 1s Mark b ’74 (MR physicist, Los Angeles).
    [Show full text]
  • The Causes and Effects of Socio-Demographic Exclusions from Clinical Trials ISSN 1366-5278 Feedback Your Views About This Report
    Health Technology Assessment Health Technology Health Technology Assessment 2005; Vol. 9: No. 38 2005; 9: No. 38 Vol. The causes and effects of socio-demographic exclusions from clinical trials The causes and effects of socio-demographic exclusions from clinical trials C Bartlett, L Doyal, S Ebrahim, P Davey, M Bachmann, M Egger and P Dieppe Feedback The HTA Programme and the authors would like to know your views about this report. The Correspondence Page on the HTA website (http://www.ncchta.org) is a convenient way to publish your comments. If you prefer, you can send your comments to the address below, telling us whether you would like us to transfer them to the website. We look forward to hearing from you. October 2005 The National Coordinating Centre for Health Technology Assessment, Mailpoint 728, Boldrewood, Health Technology Assessment University of Southampton, NHS R&D HTA Programme Southampton, SO16 7PX, UK. HTA Fax: +44 (0) 23 8059 5639 Email: [email protected] http://www.ncchta.org ISSN 1366-5278 HTA How to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (http://www.hta.ac.uk). A fully searchable CD-ROM is also available (see below). Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents. Non-UK purchasers will have to pay a small fee for post and packing.
    [Show full text]